Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Goodbody Health Ltd GDBYF

Goodbody Health Ltd is a wellness company operating in both COVID testing in the United Kingdom and as a vertically integrated cannabinoid CBD company that operates in the United Kingdom and the European Union. It has interests in COVID testing clinics, CBD extraction, wholesale bulk isolate, and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs.


GREY:GDBYF - Post by User

Post by lscfaon Feb 22, 2021 10:38am
234 Views
Post# 32625787

COVID testing expansion

COVID testing expansion

 

 

Sativa Wellness Group Inc.

(“Sativa” or “Sativa Wellness” the “Company” or the “Group”)

22nd February 2021

Launch of 8 more COVID Testing Facilities

Sativa Wellness Group is pleased to announce that our Bath and Bristol Goodbody clinics booked up to £27,000 a day in COVID testing revenues in December. Having proved the testing model in Bath and Bristol, we have rolled out a number of in-pharmacy clinics and today we open our tenth testing facility with a further twenty in-pharmacy clinics in process.
Current clinics are located in:

Bath
Bristol
Swindon
Exeter
London
Reading
Cardiff
Newport
Southampton
Cheltenham

The company is well placed to benefit from the expected easing of UK travel restrictions at the end of this lock down period.
Geremy Thomas, Executive Chairman, says: “The prospects for the company are very positive. Recent restructuring has improved our cash runway, ensuring our cash reserves remain robust. New wellness revenue streams are set to increase substantially and existing CBD revenues are anticipated to rebound as the High Street recovers from the pandemic.

The Directors of the Company accept responsibility for the contents of this announcement.

On behalf of the Board of Directors,

Geremy Thomas
Executive Chairman
Sativa Wellness Group Inc. 
+44 (0) 20 7971 1255
enquiries@sativawellnessgroup.com
www.sativawellnessgroup.com

Joseph Colliver
Chief Financial Officer
Sativa Wellness Group Inc.
+44 (0) 20 7971 1255
enquiries@sativawellnessgroup.com
www.sativawellnessgroup.com

 

AQSE Growth Market Corporate Advisor
Corporate Finance
Guy Miller/Allie Feuerlein
Peterhouse Capital Limited
+44 (0) 20 7220 9795
gm@peterhousecap.com


<< Previous
Bullboard Posts
Next >>